Skip to main content
. 2019 Jul 24;8(8):1096. doi: 10.3390/jcm8081096

Table 1.

Characteristics of EE-TP.

EE-TP Attributes Criteria
Dosage Form ~58–65 × 1010 erythrocytes suspended in saline
Thymidine-phosphorylase/erythrocytes ratio ~30–90 U/1010 erythrocytes
Dosage Volume ~150–500 mL
Route of Administration IV
Physical Description Light to dark red color, resembling venous blood

EE-TP—erythrocyte encapsulated thymidine phosphorylase; IV—intravenous.